Isorhamnetin attenuates atherosclerosis by inhibiting macrophage apoptosis via PI3K/AKT activation and HO-1 induction - Test2 - elhamkhani - TriplyDB

Isorhamnetin attenuates atherosclerosis by inhibiting macrophage apoptosis via PI3K/AKT activation and HO-1 induction

Isorhamnetin attenuates atherosclerosis by inhibiting macrophage apoptosis via PI3K/AKT activation and HO-1 induction

http://www.wikidata.org/entity/Q28544863

about

Flavonoids from Artemisia sacrorum Ledeb. and their cytotoxic activities against human cancer cell lines Hippophae rhamnoides L. Fruits Reduce the Oxidative Stress in Human Blood Platelets and Plasma.Genetic polymorphism of the Nrf2 promoter region is associated with vitiligo risk in Han Chinese populations Effect of Heme Oxygenase-1 on Mitofusin-1 protein in LPS-induced ALI/ARDS in rats.Flavonols reduce aortic atherosclerosis lesion area in apolipoprotein E deficient mice: A systematic review and meta-analysis.Myricitrin Attenuates High Glucose-Induced Apoptosis through Activating Akt-Nrf2 Signaling in H9c2 Cardiomyocytes.Isorhamnetin protects against cardiac hypertrophy through blocking PI3K-AKT pathway.SIRT1 inhibition promotes atherosclerosis through impaired autophagy.Recombinant Human Thioredoxin-1 Protects Macrophages from Oxidized Low-Density Lipoprotein-Induced Foam Cell Formation and Cell Apoptosis.Calcium homeostasis and endoplasmic reticulum stress are involved in Salvianolic acid B-offered protection against cardiac toxicity of arsenic trioxide.Ginsenoside F1 Ameliorates Endothelial Cell Inflammatory Injury and Prevents Atherosclerosis in Mice through A20-Mediated Suppression of NF-kB Signaling.Notoginsenoside R1 ameliorates diabetic encephalopathy by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation.AKT-targeted anti-inflammatory activity of calyx ethanolic extract

P2860

Q28829003-1599496F-A511-4217-8D85-E8324BF71F59 Q36532153-6BB5B7BF-314B-406A-B1FD-162DE7202344 Q37251621-3B809A6D-8EDD-499B-B4E3-CE747A200C98 Q37405611-405727E5-1D68-4A84-9527-1BD0B38FBB48 Q38662167-97FCC554-09BB-4DF9-BF95-3A8AD942C90C Q38758869-762A3785-14D9-4064-92A0-FD69516FF5E9 Q38972944-E5A546AE-BE07-4873-930E-81805DFC8FC0 Q41612831-1EA1806D-0CB6-4B27-BFF9-1FDFCE7F3521 Q46359476-91BD9FAD-9864-47D6-B4A5-6CCCC3AFE70D Q47167565-EDC6AE87-06D1-4591-82BA-C67632B01E3D Q47194713-1A3146B7-EAF1-46AC-B6D1-C05BCBBD72D5 Q52672952-A03B0267-9217-41B9-8CE6-609162B8DDB7 Q58595391-4091AFB2-4B93-4B75-A8C3-BA330371E150

P2860

Isorhamnetin attenuates atherosclerosis by inhibiting macrophage apoptosis via PI3K/AKT activation and HO-1 induction

http://www.wikidata.org/entity/Q28544863

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Isorhamnetin attenuates athero ...... activation and HO-1 induction

@ast

Isorhamnetin attenuates athero ...... activation and HO-1 induction

@en

Isorhamnetin attenuates athero ...... activation and HO-1 induction

@nl

type

label

Isorhamnetin attenuates athero ...... activation and HO-1 induction

@ast

Isorhamnetin attenuates athero ...... activation and HO-1 induction

@en

Isorhamnetin attenuates athero ...... activation and HO-1 induction

@nl

prefLabel

Isorhamnetin attenuates athero ...... activation and HO-1 induction

@ast

Isorhamnetin attenuates athero ...... activation and HO-1 induction

@en

Isorhamnetin attenuates athero ...... activation and HO-1 induction

@nl

P1433

Q28544863-384DAFA4-2163-45E9-BE78-EA2F9FEEBC8F

P1476

Q28544863-8546405A-6EAC-4484-A1EA-108419F577E2

P2093

Q28544863-37E2DA33-47BC-4FE0-BA1B-9A01EB3EF69C

Q28544863-4DB5E3C0-1EE8-475A-8A2F-D9018DC26787

Q28544863-57C1FE15-0915-415A-8F11-B885D00AC360

Q28544863-8E496CC7-9201-4F4F-AF04-E8A158FAF229

Q28544863-D04F5B00-9043-4416-8DC8-A35623B876C6

Q28544863-E95E1D58-0077-4D81-9081-C20DDE34A90B

Q28544863-EBF2B568-B4D8-41B6-88B0-AD994F461D2B

P2860

Q28544863-0A9A314A-090C-46D7-914C-66549DBCC5D8

Q28544863-0E895E7A-F1C3-4D18-AC55-F12C1DEAC306

Q28544863-11BFCBD5-8E94-4727-8356-9739E897F1B8

Q28544863-185EB923-A714-451B-A36C-99E781BC172F

Q28544863-19C48CDD-310A-4CE3-B1E0-FE827995ADF6

Q28544863-1B62FD61-7292-44B6-AEAC-65010A268CA9

Q28544863-1D3B0A9C-BB1B-43DD-9086-188AFB59FB7F

Q28544863-2AE326F1-2881-486E-B7C6-273F07FF7A57

Q28544863-2DF202A4-D30C-44AC-BD3A-0722F1828578

Q28544863-33725D27-1626-4D39-B452-149EEE3A10C9

P304

Q28544863-49378B59-2E63-48BE-9ADB-DA1D210AD310

P31

Q28544863-4DE8A513-65C5-48A2-8F8B-E89D139F9446

P3181

Q28544863-F15AA393-39D4-4FD8-9353-232868ACB8FA

P356

Q28544863-14438E4D-5BF6-421B-8190-E59682AC99EE

P407

Q28544863-67C8C7F3-342C-46EE-ACE2-FDC1775598AB

P433

Q28544863-1B437881-7C05-4AD3-99BE-231E140EB893

P478

Q28544863-B3FDFA68-CF4E-4C95-93F0-BDC63E8A8BBA

P577

Q28544863-ABC2C8FF-530A-492F-A9D7-0C2A44598089

P5875

Q28544863-1429C724-D74B-4E87-9FF8-D6D57CB03767

P698

Q28544863-E412A28E-224A-4DFF-8ADF-E8FE8B971BEF

P921

Q28544863-9715A5E5-8680-41EB-BAEA-FD2E592EEB5C

Q28544863-F1EB4FEF-F27C-48A2-AB0F-8F1A441255C4

P932

Q28544863-EDDBDE5A-8AB4-4B53-A9D9-59A2D10282A0

P3181

P356

JOURNAL.PONE.0120259

P1433

P1476

Isorhamnetin attenuates athero ...... activation and HO-1 induction

@en

P2093

Guibo Sun

http://www.w3.org/2001/XMLSchema#string

Meng Qin

http://www.w3.org/2001/XMLSchema#string

Min Wang

http://www.w3.org/2001/XMLSchema#string

Xi Dong

http://www.w3.org/2001/XMLSchema#string

Xiaobo Sun

http://www.w3.org/2001/XMLSchema#string

Yingli Yu

http://www.w3.org/2001/XMLSchema#string

Yun Luo

http://www.w3.org/2001/XMLSchema#string

P2860

Metallothionein-III protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a PI3K and ERK/Nrf2-dependent manner

Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions

Inflammation, atherosclerosis, and coronary artery disease

Cell death: critical control points

Reactive oxygen species, cellular redox systems, and apoptosis

Celastrol prevents atherosclerosis via inhibiting LOX-1 and oxidative stress

Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis

Macrophage plasticity in experimental atherosclerosis.

CD36/fatty acid translocase, an inflammatory mediator, is involved in hyperlipidemia-induced exacerbation in ischemic brain injury.

Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation.

P304

e0120259

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2601577

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0120259

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277580480

http://www.w3.org/2001/XMLSchema#string

P698

25799286

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

4370599

http://www.w3.org/2001/XMLSchema#string